CoChat

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index; 1 of the 15 sources its claims cite were checked for support.

Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex

Open access
Lu, Jiayun, Jeong, Hawon, Kong, Nikki, Yang, Youyang, Carroll, John, Luo, Hongbo R., Silberstein, Leslie E., YupoMa, Chai, Li · 2009 · PLoS ONE

Abstract

BACKGROUND: The embryonic stem cell (ESC) factor, SALL4, plays an essential role in both development and leukemogenesis. It is a unique gene that is involved in self-renewal in ESC and leukemic stem cell (LSC). METHODOLOGY/PRINCIPAL FINDINGS: To understand the mechanism(s) of SALL4 function(s), we sought to identify SALL4-associated proteins by tandem mass spectrometry. Components of a transcription repressor Mi-2/Nucleosome Remodeling and Deacetylase (NuRD) complex were found in the SALL4-immunocomplexes with histone deacetylase (HDAC) activity in ESCs with endogenous SALL4 expression and 293T cells overexpressing SALL4. The SALL4-mediated transcriptional regulation was tested on two potential target genes: PTEN and SALL1. Both genes were confirmed as SALL4 downstream targets by chromatin-immunoprecipitation, and their expression levels, when tested by quantitative reverse transcription polymerase chain reaction (qRT-PCR), were decreased in 293T cells overexpressing SALL4. Moreover, SALL4 binding sites at the promoter regions of PTEN and SALL1 were co-occupied by NuRD components, suggesting that SALL4 represses the transcriptions of PTEN and SALL1 through its interactions with the Mi-2/NuRD complex. The in vivo repressive effect(s) of SALL4 were evaluated in SALL4 transgenic mice, where decreased expressions of PTEN and SALL1 were associated with myeloid leukemia and cystic kidneys, respectively. CONCLUSIONS/SIGNIFICANCE: In summary, we are the first to demonstrate that stem cell protein SALL4 represses its target genes, PTEN and SALL1, through the epigenetic repressor Mi-2/NuRD complex. Our novel finding provides insight into the mechanism(s) of SALL4 functions in kidney development and leukemogenesis.

Overview

CoChat Summary

## TL;DR

SALL4 is shown to function as a strong transcriptional repressor by associating with the Mi-2/NuRD epigenetic repressor complex. The paper identifies PTEN and SALL1 as direct SALL4 targets whose expression is reduced in cells and in SALL4B transgenic mice.

## Key findings

  • SALL4A and SALL4B localized to the nucleus in 293T cells, and a GAL4–SALL4B fusion repressed reporter transcription in a dose-dependent manner.
  • Mass spectrometry of SALL4B immunocomplexes identified NuRD components, including Mi-2β, MTA1, MTA2, p66, HDAC1, and RbAP46; co-immunoprecipitation also detected HDAC2 and RbAP48, while Sin3A was not detected.
  • SALL4-containing complexes had HDAC activity: exogenous SALL4A/SALL4B complexes showed 2- to 5-fold higher activity than IgG controls, and endogenous SALL4 complexes in ES cells showed a 2-fold increase; TSA reduced this activity.
  • SALL4 bound PTEN and SALL1 promoter regions, and qRT-PCR showed reduced expression in 293T cells overexpressing SALL4A or SALL4B: PTEN decreased by 30% and 30%, and SALL1 decreased by 35% and 50%, respectively.
  • In SALL4B transgenic mice, 50% developed cystic kidneys; SALL1 mRNA in kidneys decreased to 45% of wild-type controls, and PTEN mRNA in bone marrow decreased by 20% versus littermate controls.

## Methods

  • The study combined protein purification/mass spectrometry, co-immunoprecipitation, HDAC assays, ChIP/qPCR, qRT-PCR, reporter assays, and mouse phenotyping/MRI/H&E staining.
  • Main experimental systems were 293T cells, D3 mouse embryonic stem cells, and SALL4B transgenic mice; ChIP-on-chip in human CD34+ cells, NB4 cells, and human ESCs is mentioned as the source of candidate target genes.
  • Analyses included promoter occupancy by SALL4 and NuRD components, transcript quantification relative to GAPDH, and comparison with input or control pull-downs.

## Limitations

  • The paper does not report sample sizes for several experiments, so statistical robustness is hard to assess from the text alone.
  • Some evidence is based on overexpression systems in 293T cells, which the text itself implies may not fully reflect endogenous regulation in native tissues.
  • The paper states that further studies are needed to define how SALL4 switches between activating and repressing targets.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0005577

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Nuclear localization of SALL4. (A) Immunofluorescence of 293T cells transfected with either SALL4A (upper panel) or SALL4B (lower panel). Cells were stained with polyclonal anti SALL4 antibody (right) and DAPI (left). Both SALL4A and SALL4B were observed only in the nuclei of transfected. (B) Cellular fractionation with Western blotting showing SALL4A and SALL4B in the nuclei. Lysates from SALL4A or SALL4B-expressed 293Tcells were fractionated. 50 ug of subcellular fractions were separated on the SDS-PAGE and probed with the anti-SALL4 antibody.
Figure 1 Nuclear localization of SALL4. (A) Immunofluorescence of 293T cells transfected with either SALL4A (upper panel) or SALL4B (lower panel). Cells were stained with polyclonal anti SALL4 antibody (right) and DAPI (left). Both SALL4A and SALL4B were observed only in the nuclei of transfected. (B) Cellular fractionation with Western blotting showing SALL4A and SALL4B in the nuclei. Lysates from SALL4A or SALL4B-expressed 293Tcells were fractionated. 50 ug of subcellular fractions were separated on the SDS-PAGE and probed with the anti-SALL4 antibody.CC BY · PubMed Central
Figure 2 Transcriptional repression by tethered SALL4B. (A) Schematic representation of the GAL4 fusion protein (GAL4–SALL4B) and luciferase reporters (GAL4-tk-Luc). 5×Gal4, five copies of the GAL4-binding site; tk, thymidine kinase core promoter. (B) Constructs expressing SALL4B fused to the C-terminus of GAL4 (1–93) were transfected into 293T cells, along with the reporter GAL-tk-Luc. Luciferase activities were normalized to the internal ß-galactosidase control. Different molar ratios of GAL4-SALL4B and GAL4-tk-Luc were used for transfection.
Figure 2 Transcriptional repression by tethered SALL4B. (A) Schematic representation of the GAL4 fusion protein (GAL4–SALL4B) and luciferase reporters (GAL4-tk-Luc). 5×Gal4, five copies of the GAL4-binding site; tk, thymidine kinase core promoter. (B) Constructs expressing SALL4B fused to the C-terminus of GAL4 (1–93) were transfected into 293T cells, along with the reporter GAL-tk-Luc. Luciferase activities were normalized to the internal ß-galactosidase control. Different molar ratios of GAL4-SALL4B and GAL4-tk-Luc were used for transfection.CC BY · PubMed Central
Figure 3 SALL4B-bound proteins include the components of Mi-2/NuRD complex. Extracts from 293Tcells expressing FLAG-SALL4B or mock vector only were immunoprecipitated with anti-FLAG M2 agarose. SALL4B-bound proteins were fractionated by SDS-PAGE, detected by silver staining and identified by tandem mass spectrometry.
Figure 3 SALL4B-bound proteins include the components of Mi-2/NuRD complex. Extracts from 293Tcells expressing FLAG-SALL4B or mock vector only were immunoprecipitated with anti-FLAG M2 agarose. SALL4B-bound proteins were fractionated by SDS-PAGE, detected by silver staining and identified by tandem mass spectrometry.CC BY · PubMed Central
Figure 4 SALL4 associates with Mi-2/NuRD complex and SALL4-interacting protein complex exhibits histone deacetylase (HDAC) activity. Extracts from SALL4B-expressed 293T cells (A), SALL4B-expressed 293T cells (B), or mouse ES cells, (C) were immunoprecipated with an anti-SALL4 antibody or rabbit IgG control followed by Western blotting with indicated antibodies. The HDAC activity of SALL4-bound protein complex was measured using the fluorimetric assay with or without the TSA (D). Data represent at least two independent experiments. Error bars denote standard deviation (SD).
Figure 4 SALL4 associates with Mi-2/NuRD complex and SALL4-interacting protein complex exhibits histone deacetylase (HDAC) activity. Extracts from SALL4B-expressed 293T cells (A), SALL4B-expressed 293T cells (B), or mouse ES cells, (C) were immunoprecipated with an anti-SALL4 antibody or rabbit IgG control followed by Western blotting with indicated antibodies. The HDAC activity of SALL4-bound protein complex was measured using the fluorimetric assay with or without the TSA (D). Data represent at least two independent experiments. Error bars denote standard deviation (SD).CC BY · PubMed Central
Figure 5 SALL4 co-occupies the same promoter regions of PTEN as HDAC2 and represses its expression in vitro. (A) Diagram of PTEN promoter. Antibody against SALL4 was used to immunoprecipitate DNA fragments from SALL4A and SALL4B-expressed 293T cells and fold enrichment was compared to input after normalization with GAPDH. Four pairs of primers in the PTEN promoter region (−2629 bp to −1419 bp) were used in ChIP-qPCR analysis with the ATG site defined as 0. Region I (−2629 bp to −2383 bp) was found to be bound by SALL4B and region III (−1706 bp to −1571 bp) was found to be bound by both SALL4A and SALL4B (B). The same ChIP-qPCR assay was done with an anti-HDAC2 antibody (C) or an anti-acetyl H3 antibody (D). Results are representative of at least two independent experiments. Error bars indicate standard deviations. NA: no amplicon in qPCR. (E) The expression level of PTEN was reduced 30% in SALL4-expressed 293T cells (SALL4A and SALL4B) compared to empty vector controls (EV). The mRNA level was normalized with internal control GAPDH. Data represent as mean±SD, n≥3, P<0.05.
Figure 5 SALL4 co-occupies the same promoter regions of PTEN as HDAC2 and represses its expression in vitro. (A) Diagram of PTEN promoter. Antibody against SALL4 was used to immunoprecipitate DNA fragments from SALL4A and SALL4B-expressed 293T cells and fold enrichment was compared to input after normalization with GAPDH. Four pairs of primers in the PTEN promoter region (−2629 bp to −1419 bp) were used in ChIP-qPCR analysis with the ATG site defined as 0. Region I (−2629 bp to −2383 bp) was found to be bound by SALL4B and region III (−1706 bp to −1571 bp) was found to be bound by both SALL4A and SALL4B (B). The same ChIP-qPCR assay was done with an anti-HDAC2 antibody (C) or an anti-acetyl H3 antibody (D). Results are representative of at least two independent experiments. Error bars indicate standard deviations. NA: no amplicon in qPCR. (E) The expression level of PTEN was reduced 30% in SALL4-expressed 293T cells (SALL4A and SALL4B) compared to empty vector controls (EV). The mRNA level was normalized with internal control GAPDH. Data represent as mean±SD, n≥3, P<0.05.CC BY · PubMed Central
Figure 6 SALL4 co-occupies the same promoter regions of SALL1 as HDAC2 and inhibits its transcription in vitro. (A) Diagram of SALL1 promoter. Antibody against SALL4 was used to immunoprecipitate DNA fragments from SALL4A and SALL4B-expressed 293T cells and fold enrichment was compared to input after normalization with GAPDH. Five pairs of primers spanning SALL1 promoter region (−2246 bp to −1279 bp) were used in ChIP-qPCR analysis. Region II (−2057 bp to −1867 bp) was found to be bound by SALL4A and region V (−1464 bp to −1279 bp) was found to be bound by SALL4B (B). The same ChIP-qPCR assay was done with an anti-HDAC2 antibody (C) or an anti-acetyl H3 antibody (D). Results are representative of at least two independent experiments. Error bars indicate standard deviations. NA: no amplicon in qPCR. ND: not done. (E) The mRNA level of SALL1 was reduced 35% and 45% in SALL4A and SALL4B-expressed 293T cells (SALL4A and SALL4B) compared to empty vector controls (EV). The expression level was normalized with internal control GAPDH. Data represent as mean±SD, n≥3, P<0.05.
Figure 6 SALL4 co-occupies the same promoter regions of SALL1 as HDAC2 and inhibits its transcription in vitro. (A) Diagram of SALL1 promoter. Antibody against SALL4 was used to immunoprecipitate DNA fragments from SALL4A and SALL4B-expressed 293T cells and fold enrichment was compared to input after normalization with GAPDH. Five pairs of primers spanning SALL1 promoter region (−2246 bp to −1279 bp) were used in ChIP-qPCR analysis. Region II (−2057 bp to −1867 bp) was found to be bound by SALL4A and region V (−1464 bp to −1279 bp) was found to be bound by SALL4B (B). The same ChIP-qPCR assay was done with an anti-HDAC2 antibody (C) or an anti-acetyl H3 antibody (D). Results are representative of at least two independent experiments. Error bars indicate standard deviations. NA: no amplicon in qPCR. ND: not done. (E) The mRNA level of SALL1 was reduced 35% and 45% in SALL4A and SALL4B-expressed 293T cells (SALL4A and SALL4B) compared to empty vector controls (EV). The expression level was normalized with internal control GAPDH. Data represent as mean±SD, n≥3, P<0.05.CC BY · PubMed Central
Figure 7 SALL4 represses the transcriptions of PTEN and SALL1 in vivo. Cystic kidneys were observed in 50% of the SALL4B transgenic mice. (A) MRI imaging on mouse kidneys. Compared to the control normal kidney, the cystic kidney had a 1.35 mm cyst that is indicated by an arrow. The gross picture of a cystic kidney was shown in (B) with the arrow indicating the cystic area. (C) Histological morphologies on normal kidney (C–I, magnification: ×40) and cystic kidneys (C-ii and C-iii indicated by the arrow, ×40) were presented after stained with Hematoxylin and Eosin (H&E stain). (D) Normal bone marrow from control mice (H&E stain with magnification: ×100). (E) Leukemic bone marrow from transgenic mice (H&E stain with magnification: ×100). (F) The transcriptions of PTEN or SALL1 were decreased 20% and 45% respectively in SALL4B transgenic mice BM or kidney samples. Data represent as mean±SD, n = 4, P<0.05.
Figure 7 SALL4 represses the transcriptions of PTEN and SALL1 in vivo. Cystic kidneys were observed in 50% of the SALL4B transgenic mice. (A) MRI imaging on mouse kidneys. Compared to the control normal kidney, the cystic kidney had a 1.35 mm cyst that is indicated by an arrow. The gross picture of a cystic kidney was shown in (B) with the arrow indicating the cystic area. (C) Histological morphologies on normal kidney (C–I, magnification: ×40) and cystic kidneys (C-ii and C-iii indicated by the arrow, ×40) were presented after stained with Hematoxylin and Eosin (H&E stain). (D) Normal bone marrow from control mice (H&E stain with magnification: ×100). (E) Leukemic bone marrow from transgenic mice (H&E stain with magnification: ×100). (F) The transcriptions of PTEN or SALL1 were decreased 20% and 45% respectively in SALL4B transgenic mice BM or kidney samples. Data represent as mean±SD, n = 4, P<0.05.CC BY · PubMed Central
Figure 8 Proposed functional model for SALL4/NuRD complex. SALL4 recruits the NuRD complex to the specific promoter regions on its target genes (i.e. PTEN and SALL1). This results in histone deacetylation at these regions, which leads to condensed heterochromatin and repressed gene expressions.
Figure 8 Proposed functional model for SALL4/NuRD complex. SALL4 recruits the NuRD complex to the specific promoter regions on its target genes (i.e. PTEN and SALL1). This results in histone deacetylation at these regions, which leads to condensed heterochromatin and repressed gene expressions.CC BY · PubMed Central
Figure 9 Working hypothesis:SALL4 recruits epigenetic modulators to specific DNA sequences on the promoter regions of its downstream targets. A, SALL4 represses its downstream targets by recruiting NuRD to specific promoter regions that results in histone deacetylation and transcription repression. B, SALL4 activates its downstream targets by recruiting a histone methyltransferase complex to specific promoter regions that results in H3-K4 trimethylation and transcription activation. C, Alternatively, SALL4 recruits both complexes to specific regions on the promoters of target genes. It can either repress or activate the transcription of these genes by balancing the interactions with both complexes.
Figure 9 Working hypothesis:SALL4 recruits epigenetic modulators to specific DNA sequences on the promoter regions of its downstream targets. A, SALL4 represses its downstream targets by recruiting NuRD to specific promoter regions that results in histone deacetylation and transcription repression. B, SALL4 activates its downstream targets by recruiting a histone methyltransferase complex to specific promoter regions that results in H3-K4 trimethylation and transcription activation. C, Alternatively, SALL4 recruits both complexes to specific regions on the promoters of target genes. It can either repress or activate the transcription of these genes by balancing the interactions with both complexes.CC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 0 Not valid · 13 Not checked · 30 Own results and interpretations

19 more claims

Create a free account to see all 44 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 16
  • Probably not a substantial claim. 11

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 51 references

Research works printed but not linked: 1

  1. J Yang, 2008, SALL4 is a key regulator of survival and apoptosis in human leukemic cells., Blood, 112(3), 805, 10.1182/blood-2007-11-126326 · DOI · Paper page

Cited by

See all 168

Metadata

Authors
Lu, J., Jeong, H., Kong, N., Yang, Y., Carroll, J., Luo, H. R., Silberstein, L. E., YupoMa, & Chai, L.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Chai, Li
Venue
PLoS ONE
Published
2009-05-18
Volume
4
Issue
5
Pages
e5577
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2122638939
Cited by
168
References
51
Citations by year
2026: 3 · 2025: 7 · 2024: 4 · 2023: 12 · 2022: 12 · 2021: 10 · 2020: 6 · 2019: 11 · 2018: 11 · 2017: 11 · 2016: 9 · 2015: 14 · 2014: 10 · 2013: 13 · 2012: 9
FWCI
4.56
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health
  • Harvard Stem Cell Institute
  • National Heart, Lung, and Blood Institute (R01HL092437)
  • National Cancer Institute (K08CA097185)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K08DK063220)
  • National Center for Research Resources (P20RR016464)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
SALL4, PTEN, SALL1, NuRD complex, histone deacetylase, transcriptional repression, epigenetic repression, embryonic stem cells, leukemia stem cells, myeloid leukemia, renal cysts, kidney development
MeSH terms
Animals, Binding Sites, Cell Line, Histone Deacetylases, Humans, Immunohistochemistry, Magnetic Resonance Imaging, Mice, Transgenic, Promoter Regions, Genetic, Protein Binding, Mass Spectrometry, Transcription Factors, Reverse Transcriptase Polymerase Chain Reaction, Chromatin Immunoprecipitation, Immunoprecipitation, PTEN Phosphohydrolase, Mice, Mi-2 Nucleosome Remodeling and Deacetylase Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex. https://app.cochat.ai/papers/10.1371/journal.pone.0005577
The paper
Lu, J., Jeong, H., Kong, N., Yang, Y., Carroll, J., Luo, H. R., Silberstein, L. E., YupoMa, & Chai, L. (2009). Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex. PLoS ONE. https://doi.org/10.1371/journal.pone.0005577

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.